Natural compounds: the future of anti-malarial treatment

March 14, 2011

In the run up to World Malaria Day on the 25th April 2011, BioMed Central's open access journal Malaria Journal takes a long hard look at the development of natural compounds for use in the fight against malaria.

There are over 200 million cases of each year with 85% of all cases being children under five years old and, according to the World Health Organisation, in 2009 malaria was responsible for 781,000 deaths worldwide. Low cost treatment is available, 100 million children a year are treated with Artemisinin combination therapy at a cost of about 30 cents per child, but resistance of the parasite to this treatment is increasing. In the face of this resistance, researchers are turning to traditional medicine to provide a starting point for the development of .

Traditional remedies are widely used especially in areas of poverty or where there is no access to medical treatment. The combination of artemisinin, flavanoids, and other compounds which occur naturally in the leaves of Artemisia annua, increases the effectiveness of the treatment and decreases metabolism of the active ingredient. Curcumin (from turmeric) has anti-malarial properties and is being tested for use against . Adding piperine (from black pepper seeds) to curcumin increases the effectiveness of curcumin 2000 times. Plant extracts such as lemon eucalyptus, citronella, and neem oil also have use as insect repellents but are not as yet recommended for use by the .

Researchers suggest following the Research Initiative on Traditional Anti-Malarial Methods (RITAM), which shows a consensus of observational and laboratory results with clinical clearance of parasites. They also advocate the inclusion of native healers for the review of disease surveillance, ethnobotanical treatments, and changes in health care policy to increase the validity of these traditional medicines.

However, there is currently no concerted research into the effectiveness of as anti-malarials or as malaria prophylaxis. Consequently, there is a need for partnership organisations, such as African Network for Drugs and Diagnostics Innovation (ANDi), to promote standardisation in observing traditional remedies and the subsequent pharmacological purification and testing of compounds and combinations in the clinic.

More information: 1.1. A call for using natural compounds in the development of new antimalarial treatments– an introduction
Hagai Ginsburg and Eric Deharo
Malaria Journal (in Press)

1.2. How can natural products serve as a viable source of lead compounds for the development of new/novel anti-malarials?
Eric Guantai and Kelly Chibale
Malaria Journal (in Press)

1.3. Natural products as starting points for future anti-malarial therapies: going back to our roots?
Timothy NC Wells
Malaria Journal (in Press)

1.4. Whole plant extracts versus single compounds for the treatment of malaria: synergy and positive interactions
Philippe Rasoanaivo, Colin W Wright, Merlin L Willcox and Ben Gilbert
Malaria Journal (in Press)

1.5. Analysis of additivity and synergism in the anti-plasmodial effect of purified compounds from plant extracts
Eric Deharo and Hagai Ginsburg
Malaria Journal (in Press)

1.6. To what extent can traditional medicine contribute a complementary or alternative solution to malaria control programmes?
Bertrand Graz, Andrew Y Kitua and Hamisi M Malebo
Malaria Journal (in Press)

1.7. Do ethnobotanical and laboratory data predict clinical safety and efficacy of anti-malarial plants?
Merlin Willcox, Françoise Benoit-Vical, Dennis Fowler, Geneviève Bourdy, Gemma Burford, Sergio Giani, Rocky Graziose, Peter
Houghton, Milijaona Randrianarivelojosia and Philippe Rasoanaivo
Malaria Journal (in Press)

1.8. A "reverse pharmacology" approach for developing an anti-malarial phytomedicine
Merlin L Willcox, Bertrand Graz, Jacques Falquet, Chiaka Diakite, Sergio Giani and Drissa Diallo
Malaria Journal (in Press)

1.9. Traditional medicines as a mechanism for driving research innovation in Africa
Ivan Addae-Mensah, Foluke Fakorede, Andreas Holtel and Solomon Nwaka
Malaria Journal (in Press)

1.10. The plant-based immunomodulator curcumin as a potential candidate for the development of an adjunctive therapy for cerebral malaria
Patrice N Mimche, Donatella Taramelli and Livia Vivas
Malaria Journal (in Press)

1.11. Plant-based insect repellents: a review of their efficacy, development and testing
Marta Ferreira Maia and Sarah J Moore
Malaria Journal (in Press)

Related Stories

Recommended for you

Study seeks to aid diagnosis, management of catatonia

December 11, 2017
Catatonia, a syndrome of motor, emotional and behavioral abnormalities frequently characterized by muscular rigidity and a trance-like mental stupor and at times manifesting with great excitement or agitation, can occur during ...

New compound stops progressive kidney disease in its tracks

December 7, 2017
Progressive kidney diseases, whether caused by obesity, hypertension, diabetes, or rare genetic mutations, often have the same outcome: The cells responsible for filtering the blood are destroyed. Reporting today in Science, ...

New Lyme disease tests could offer quicker, more accurate detection

December 7, 2017
New tests to detect early Lyme disease - which is increasing beyond the summer months -could replace existing tests that often do not clearly identify the infection before health problems occur.

Spinal tap needle type impacts the risk of complications

December 6, 2017
The type of needle used during a lumbar puncture makes a significant difference in the subsequent occurrence of headache, nerve irritation and hearing disturbance in patients, according to a study by Hamilton medical researchers.

Men with HPV are 20 times more likely to be reinfected after one year

December 5, 2017
A new analysis of genital human papillomavirus (HPV) in men shows that infection with one HPV type strongly increases the risk of reinfection with the same type. In fact, men who are infected with the type responsible for ...

New tuberculosis drugs possible with understanding of old antibiotic

December 5, 2017
Tuberculosis, and other life-threatening microbial diseases, could be more effectively tackled with future drugs, thanks to new research into an old antibiotic by the University of Warwick and The Francis Crick Institute.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

not rated yet Mar 22, 2011
Good article and, by the way, the extract from curcuma longa or turmeric is called curcumin, not circumin!

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.